Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.38 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.34 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | SRC | P12931 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10698543 | 0.97 | TDP1 (0.43) | TDP1SMN1; SMN2SLC22A6FOLH1GABRR1 | |
| Hydrogen Peroxide SCHEMBL28115963 | 0.97 | TDP1 (0.43) | TDP1SMN1; SMN2SLC22A6FOLH1GABRR1 | |
| SCHEMBL42084 | 0.97 | TDP1 (0.43) | TDP1SMN1; SMN2SLC22A6FOLH1GABRR1 | |
| SCHEMBL987086 | 0.97 | TDP1 (0.43) | TDP1SMN1; SMN2SLC22A6FOLH1GABRR1 | |
| SCHEMBL10698540 | 0.97 | TDP1 (0.43) | TDP1SMN1; SMN2SLC22A6FOLH1GABRR1 | |
| SCHEMBL9777404 | 0.97 | TDP1 (0.43) | TDP1SMN1; SMN2SLC22A6FOLH1GABRR1 | |
| SCHEMBL10698553 | 0.97 | TDP1 (0.43) | TDP1SMN1; SMN2SLC22A6FOLH1GABRR1 | |
| SCHEMBL11360544 | 0.97 | TDP1 (0.43) | TDP1SMN1; SMN2SLC22A6FOLH1GABRR1 | |
| SCHEMBL11346775 | 0.95 | TDP1 (0.42) | TDP1SMN1; SMN2SLC22A6FOLH1GABRR1 | |
| SCHEMBL10777605 | 0.95 | TDP1 (0.42) | TDP1SMN1; SMN2SLC22A6FOLH1GABRR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11083696-B2 | Dispersion anaesthetic device | UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) | 2021-08-10 | — | — | US | claimed |
| EP-3326677-A1 | INHALABLE MICROEMULSION COMPRISING ANAESTHETIC | University College Cardiff Consultants Limited (GB) | 2018-05-30 | — | — | EP | claimed |
| US-20180085325-A1 | DISPERSION ANAESTHETIC DEVICE | UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) | 2018-03-29 | — | — | US | claimed |
| US-9827394-B2 | Dispersion anaesthetic device | UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) | 2017-11-28 | — | — | US | claimed |
| US-20140216456-A1 | DISPERSION ANAESTHETIC DEVICE | UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) | 2014-08-07 | — | — | US | claimed |
| EP-2758114-A2 | INHALABLE MICROEMULSION COMPRISING ANAESTHETIC | University College Cardiff Consultants, Ltd. (GB) | 2014-07-30 | — | — | EP | claimed |
| WO-2013041850-A2 | DISPERSION ANAESTHETIC DEVICE | UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) | 2013-03-28 | — | — | WO | claimed |
| US-5393461-A | For use in cosmetics, paints, drugs,inks; mixing powder with anionic, cationic, amphoteric, nonionic surfactants, oils, solvents, wetting agents and water, emulsification | RTD CORPORATION (US) | 1995-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11083696-B2 | Dispersion anaesthetic device | ADRA1D, CHRM5, ADRA2C | TDP1 2595/4885SMN1; SMN2 687/4885SLC22A6 2575/4885 |
| US-20180085325-A1 | DISPERSION ANAESTHETIC DEVICE | ADRA1D, CHRM5, ADRA2C | TDP1 2595/4885SMN1; SMN2 687/4885SLC22A6 2575/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.